Research
FORUM TRANSCRIPT

Pacific Biosciences – Short-read Sequencing Entry Through Omniome Acquisition – 29 July 2021

  • Public Equity
  • Healthcare
  • Global
PREMIUM

Specialist

Former Senior Field Application Scientist at Pacific Biosciences of California Inc

Agenda

  • Short-read and long-read sequencing – recent trends and developments
  • Pacific Biosciences' (NASDAQ: PACB) expansion into short-read sequencing via the pending acquisition of Omniome
  • Competitive landscape, highlighting major players' key differentiations
  • H2 2021 outlook and longer-term growth expectations

Questions

For access to this and thousands of other Transcripts, request a free trial

Request A Demo